- Home
- PED vs CGTX Comparison
PED vs CGTX Comparison
Compare PED & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- CGTX
- Stock Information
- Founded
- PED N/A
- CGTX 2007
- Country
- PED United States
- CGTX United States
- Employees
- PED N/A
- CGTX N/A
- Industry
- PED Oil & Gas Production
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- CGTX Health Care
- Exchange
- PED Nasdaq
- CGTX Nasdaq
- Market Cap
- PED 87.9M
- CGTX 79.3M
- IPO Year
- PED N/A
- CGTX 2021
- Fundamental
- Price
- PED $0.87
- CGTX $0.46
- Analyst Decision
- PED Strong Buy
- CGTX Buy
- Analyst Count
- PED 2
- CGTX 6
- Target Price
- PED $2.00
- CGTX $8.00
- AVG Volume (30 Days)
- PED 79.2K
- CGTX 633.0K
- Earning Date
- PED 11-26-2024
- CGTX 11-13-2024
- Dividend Yield
- PED N/A
- CGTX N/A
- EPS Growth
- PED 125.69
- CGTX N/A
- EPS
- PED 0.02
- CGTX N/A
- Revenue
- PED $35,719,000.00
- CGTX N/A
- Revenue This Year
- PED $25.95
- CGTX N/A
- Revenue Next Year
- PED $21.52
- CGTX N/A
- P/E Ratio
- PED $36.22
- CGTX N/A
- Revenue Growth
- PED 19.19
- CGTX N/A
- 52 Week Low
- PED $0.61
- CGTX $0.34
- 52 Week High
- PED $1.10
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- PED 36.05
- CGTX 43.54
- Support Level
- PED $0.89
- CGTX $0.48
- Resistance Level
- PED $0.92
- CGTX $0.62
- Average True Range (ATR)
- PED 0.03
- CGTX 0.05
- MACD
- PED -0.00
- CGTX 0.00
- Stochastic Oscillator
- PED 8.46
- CGTX 11.92
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.